BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Breaking News: BioWorld Science 2025 Year in Review
Breaking News: BioWorld 2025 Year in Review
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Teijin reports vitamin D3 derivatives for osteoporosis
May 3, 1996
V-411 approved for marketing in China
April 26, 1996
Pulmonary insulin enters phase II
April 26, 1996
OT-5226: New antidiabetic from Otsuka
April 26, 1996
Amgen presents NESP
April 26, 1996
Three beta3-adrenoceptor agonists in preclinical stage at BMS
April 26, 1996
MTP inhibitor BMS-201038 in development for hyperlipidemia
April 26, 1996
Colestimide NDA filing imminent
April 26, 1996
Otsuka evaluates hypolipidemic agents
April 26, 1996
Sanofi Winthrop discovers potent ATP-citrate lyase inhibitor
April 26, 1996
Previous
1
2
…
1777
1778
1779
1780
1781
1782
1783
1784
1785
1786
Next